Avizen Biopharma Private Limited

Avizen Biopharma Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
CIN U24304AS2016PTC017532 Incorporated 09 August 2016 ROC Guwahati HQ Guwahati, Assam, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹20.61 Cr
▲ 272% YoY
Net profit · FY 2025
₹32.92 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹1.1 Cr
EBITDA margin 5.3%
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹5.42 Cr
Issued & subscribed
Open charges
₹6.1 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
16
Provident fund records

About Avizen Biopharma Private Limited

Data last updated:

Avizen Biopharma Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24304AS2016PTC017532. Its GSTIN is 18AAOCA6748E1ZC (Assam). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹5.42 Cr. It is led by directors including Rajendra Kumar Verma and Mahendra Kumar Verma.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.61 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32.92 Lakh (net margin 1.6%) and EBITDA of ₹1.1 Cr (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 68% over five years.

The company has about 16 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹6.1 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 3 cases are pending.

Avizen Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0000303). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24304AS2016PTC017532
Registration Number 017532
Incorporation Date 09 August 2016
ROC Guwahati
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AS-16-0000303

Recognitions & Rankings of Avizen Biopharma

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-AS-16-0000303

Contact details

Avizen Biopharma Private Limited's registered office is in Guwahati, Assam. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Avizen Biopharma Private Limited, buy the company report.

Comprehensive company report
Avizen Biopharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Avizen Biopharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Avizen Biopharma Private Limited, buy the company report.

Financials of Avizen Biopharma Private Limited

FY 2024 filings available

Avizen Biopharma Private Limited reported revenue of ₹20.61 Cr (up 272% YoY) for FY 2025.

Revenue · FY 2025
₹20.61 Cr ▲ 272%
Net profit · FY 2025
₹32.92 Lakh margin 1.6%
EBITDA · FY 2025
₹1.1 Cr margin 5.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 272%
3 years · compounded
▲ 65%
5 years · compounded
▲ 68%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 98%
5 years · compounded
▲ 36%

Revenue has grown at a compounded annual rate (CAGR) of 68% over five years, including 272% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.1 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹32.92 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.3%
Net Profit Margin1.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avizen Biopharma Private Limited, buy the company report.

Board of directors of Avizen Biopharma Private Limited

Avizen Biopharma has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajendra Kumar VermaDirector09 Aug 201610 Years 3 MonthsCurrent
Mahendra Kumar VermaDirector09 Aug 201610 Years 3 MonthsCurrent
Sunil Kumar KhemaniDirector25 Feb 20179 Years 8 MonthsCurrent
Alka VermaDirector17 Jul 20251 Years 4 MonthsCurrent

Peer comparison

Avizen Biopharma Private Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biopharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aspen Biopharma Labs Private Limited₹33.52 Cr (FY 2022)161.0%Hyderabad, Telangana, India
Wembrace Biopharma Private Limited₹30.3 Cr (FY 2025)-10.0%New Delhi, Delhi, India
Avizen Biopharma Private Limitedthis company₹20.61 Cr (FY 2025)₹32.92 Lakh1.6%272.0%16Guwahati, Assam, India
Escientia Biopharma Private Limited₹20.04 Cr (FY 2025)-79.0%Hyderabad, Telangana, India
Cennet Biopharma Private Limited₹18.59 Cr (FY 2024)27.0%Delhi, India

To see the full peer comparison of Avizen Biopharma Private Limited, buy the company report.

Auditor

Avizen Biopharma Private Limited is audited by Hari Singh & Associates for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Hari Singh & AssociatesFY 2024323509E

Shareholding

The shareholding of Avizen Biopharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Avizen Biopharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹6.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Dec 2021100516420Others₹18.5 LakhOpen
29 Sep 2020100397271Others₹36.8 LakhOpen
30 Mar 2017100094089Others₹5.55 CrOpen

To see the full charge records of Avizen Biopharma Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

Avizen Biopharma Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 173 overdue payments to 38 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 38)

SupplierAmount dueDue sinceReported on
Parkash Industries
Mahima Lifesciences Private Limited
Yurvie Packaging Pvt Ltd
an individual supplier
an individual supplier

To see the full MSME payment records of Avizen Biopharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Avizen Biopharma Private Limited has a workforce of 16 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
16
Active EPFO establishments
1
Employee growth
23.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2716
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20

To see the full employee and EPFO history of Avizen Biopharma Private Limited, buy the company report.

GST

Avizen Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
18AAOCA6748E1ZCAssamActive01 Jul 2017

To see the full GST registrations and return filing status of Avizen Biopharma Private Limited, buy the company report.

Recent activity

Avizen Biopharma Private Limited has 9 board changes on record since 2016: 4 appointments and 5 cessations. The latest: Alka Verma ceased to be Additional Director on 29 Sep 2025.

Ceased
Alka Verma ceased to be Additional Director.
Charges
A charge with Others of Rs. 5.55 Cr registered on 30 Mar 2017 with Charge ID 100094089 was modified on 14 Aug 2025.
Ceased
Subhkaran Verma ceased to be Additional Director.
Appointed
Alka Verma was appointed as Director.
AGM
Avizen Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Avizen Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati.
Ceased
Rajendra Kumar Verma ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.19 Cr with Charge ID 100516420 was registered on 04 Dec 2021.
Charges
A charge with Others amounted to Rs. 0.37 Cr with Charge ID 100397271 was registered on 29 Sep 2020.
Ceased
Sunil Kumar Khemani ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 5.55 Cr with Charge ID 100094089 was registered on 30 Mar 2017.
Appointed
Sunil Kumar Khemani was appointed as Director.

4 earlier events are in the company report.

Frequently asked questions

Avizen Biopharma is an active private limited company based in Guwahati, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 August 2016 (10+ years old) and is registered under CIN U24304AS2016PTC017532.

Avizen Biopharma has 4 current directors:

The latest financial statements of Avizen Biopharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Avizen Biopharma is 18AAOCA6748E1ZC, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Avizen Biopharma is U24304AS2016PTC017532. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avizen Biopharma has 5 court cases on record: 2 filed by the company and 3 filed against it. 3 are pending. Most are in the district courts.

Avizen Biopharma was incorporated on 09 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Guwahati.

The peers of Avizen Biopharma by revenue are Aspen Biopharma Labs Private Limited, Wembrace Biopharma Private Limited, Escientia Biopharma Private Limited, Cennet Biopharma Private Limited, all in the Biotechnology industry (Biopharma), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Alka Verma ceased to be Additional Director on 29 Sep 2025. Subhkaran Verma ceased to be Additional Director on 19 Jul 2025. Alka Verma was appointed as Director on 17 Jul 2025. Avizen Biopharma has 9 board changes on record in total.

Yes, Avizen Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-AS-16-0000303).

Avizen Biopharma has 7 MSME Form 1 returns on record between 2019 and 2022, listing 173 overdue payments to 38 micro and small suppliers. The latest return was filed on 30 Jun 2022.

The registered office of Avizen Biopharma is at Sagar Bizz Plex 1st Floor S.R. Bora Lane G.S. Road Ulubari, Guwahati, Assam, India – 781007.